9th July, 2018

IBI Lorenzini meet FMD challenges head on and in advance of deadline

We are pleased to report that our Italian-based group company IBI Lorenzini has partnered with Tracelink to implement global serialisation solutions ahead of the February 2019 FMD deadline.

The IBI Lorenzini commercial operation brings together traditional pharma and contract manufacturing expertise therefore it was important for the group to find a partner that could provide the specialist knowledge on its global ‘track and trace’ requirements.  The flexibility, scalability, speed and efficiency of the Tracelink EU hub have met the IBI group’s stringent requirements.

The Falsified Medicines Directive (FMD) and the US Drug Supply Chain Security Act (DSCSA) legislation have presented the pharmaceutical industry with one of the most challenging undertakings in recent times. Investment in the IBI Lorenzini plant and in the right partnerships has therefore been crucial to a smooth implementation.

With a booming export division in over 20 countries across 5 continents the IBI Lorenzini group and UK distributor Bowmed Ibisqus will be well placed to meet the challenges of the future, with Tracelink on board.

Further information regarding the partnership can be found here